Johnson and Johnson await approval for distribution of vaccine
Johnson & Johnson takes the next big step in production for its coronavirus (COVID-19) vaccine requesting emergency authorization for use from the FDA. This request comes weeks after the release of the promising data of 66% effective in protecting against the virus.
Johnson & Johnson says that it could produce 1 billion doses of its COVID-19 vaccine — enough to vaccinate about an eighth of the world’s population — by the end of the year. https://t.co/oHnVcQeaqM
— Science News (@ScienceNews) February 5, 2021
If the new vaccine is approved, Johnson & Johnson will offer the third COVID-19 vaccine approved for emergency use in the U.S. and will also start the process of approval for worldwide use. The vaccine created by Johnson & Johnson was designed with accessibility that only requires a single-dose compared to competing vaccines.
Johnson & Johnson is ready to start distribution immediately after approval and promises to work with great urgency making the vaccine available to the public. The FDA scheduled a meeting with the Vaccines and Related Biological Products Advisory Committee to discuss the emergency use authorization on February 26.
The FDA will be following a similar protocol for other COVID-19 vaccines while making all the data available to the public. The committee will also cover the delivery methods of one dose that will be easier logically easier for health-care providers.
The pharmaceutical company #JohnsonandJohnson is preparing to seek U.S. government approval for its one-dose, easily transportable #COVID19 vaccine. And it's the 'one-dose' that's creating a lot of buzz. CGTN's John Terrett reports. pic.twitter.com/O8tGEp5sZk
— CGTN America (@cgtnamerica) February 4, 2021
The data will also cover the testing of COVID-19 variants with 66% protection against COVID-19 and 57% effectiveness against the South Africa (B.1.351) strain. Despite Johnson and Johnson having lower effective rates than the competing vaccines but offers 100% effectiveness in preventing hospitalization and death from COVID-19.
Despite having some competition, Johnson and Johnson have already created a deal back in August with the Department of Health and Human Services for $1 billion to provide 100 million doses. The contract for this deal also includes a stipulation giving the federal government the option of ordering ad additional 200 million doses.
Every Play And Penalty From Super Bowl LV
-
Neal Brij Sidhwaney Faces Potential Prison Sentence for Voiced Threats Against Unnamed Supreme Court Justice. Neal Brij Sidhwaney, a...
-
Silver Sedan Hits Secret Service Vehicle in Wilmington Incident; President and First Lady Safely Evacuated. President Joe Biden and...
-
Concerns Rise as Inner Circle Signals Retribution Against Opponents and Media Recent statements from key allies within Donald Trump’s...
-
President Biden’s U.S. Fish and Wildlife Service takes crucial steps to protect wolverines in the face of climate change,...
-
President Biden invokes the Defense Production Act to strengthen American supply chains. In a strategic move to fortify American...
-
An alarming surge in harassment prompts security concerns, as court staff, including Judge Engoron and his clerk, grapple with...
-
President Biden adds a touch of humor to the annual Thanksgiving turkey Jokes ceremony. President Joe Biden marked his...
-
Former First Lady’s Legacy Lives On in Dedication to Caregiving, Peace, and Mental Health Reform The Carter Center announces...
-
Is the Tension Between China and the U.S. Increasing? Following four hours of straightforward summit talks on the outskirts...
-
Secretary of State Antony Blinken calls for de-escalation as fighting displaces millions and raises concerns for upcoming Congo elections....
-
Taking Precautions in Uganda and Kenya for Safe Travels The U.S. Embassy has recently issued important security alerts for...
-
White House Reveals Disturbing Executions and Threats in Conflict The White House has disclosed deeply concerning information regarding the...